Rachel Meyers
Geen lopende functies
Vermogen: - $ op 30-04-2024
Profiel
Dr. Rachel Meyers is an Independent Director at Korro Bio, Inc. She is on the Board of Directors at Korro Bio, Inc. Dr. Meyers was previously employed as a Senior Vice President-Research by Alnylam Pharmaceuticals, Inc., a Senior Scientist by Takeda Oncology Co., and a Chief Scientific Officer by Faze Medicines, Inc. She received her undergraduate degree from Brandeis University and a doctorate degree from Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
-.--% | 27-11-2023 | 0 ( -.--% ) | - $ | 30-04-2024 |
Actieve functies van Rachel Meyers
Bedrijven | Functie | Begin |
---|
Eerdere bekende functies van Rachel Meyers
Bedrijven | Functie | Einde |
---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2003 |
Faze Medicines, Inc. | Oprichter | - |
ALNYLAM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Rachel Meyers
Massachusetts Institute of Technology | Doctorate Degree |
Brandeis University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Faze Medicines, Inc. |